Matthew de Ruyter, MD
Adult Reconstructive Orthopaedic Surgery · Kansas City, KSNPI 1396206868
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (44.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Smith+Nephew at 45.2% of the total. 2025 is the largest year on record at $9,386, 3.9 times the $2,400 reported in 2021.
Across 96 payments — averaging $235.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10K
- Stryker$6K
- Titan Surgical Group, LLC$4K
- Zimmer Biomet$1K
- Johnson & Johnson$937
- Orthalign Inc$154
- plus $271 from 3 others
What the payments were for
- Grants$10,00044%
- Travel & lodging$3,14114%
- Food & beverage$5,84526%
- Education$3,61716%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $10,220 |
| Stryker | 69 | $6,345 |
| Titan Surgical Group, LLC | 4 | $3,620 |
| Zimmer Biomet | 9 | $1,056 |
| Johnson & Johnson | 4 | $937 |
| Orthalign Inc | 1 | $154 |
| Medical Device Business Services, Inc. | 1 | $145 |
| Innovation Technologies Inc | 1 | $111 |
| Sonex Health, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$3,741
- ACTIS$794
- Actishield$359
- Persona$333
- ORTHALIGN PLUS$154
- AEQUALIS$153
- K-15 PORK$152
- POLARSTEM$152
- HAMMR CURVED G7 IMPACTOR$150
- RECLAIM$145
- EMPHASYS$145
- Kincise$145
- PANGEA$128
- T2$121
- Irrisept$111
- OSS Orthopedic Salvage System$101
How this compares
Too few adult reconstructive orthopaedic surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $107 |
| Meloxicam | 22 | $70 |
| Oxycodone Hcl | 19 | $60 |
| Ondansetron Hcl | 15 | $47 |
| Omeprazole | 12 | $34 |
| Tramadol Hcl | 17 | $33 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Kansas City
- Andrew MurthaKansas City$9K
- Tarun BhargavaWichita$534K
- Kelly HendricksOverland Park$250K
- Jonathon SalavaTopeka$52K
- Andrew PalmisanoOverland Park$40K
- Michael PerryOverland Park$14K
- Scott WingerterLeawood$5K
- Paul PappademosWichita$4K
- Benjamin YoungWichita$4K
- Adam GoodyearLawrence$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.